Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Primary Myelofibrosis × Capecitabine × Clear all

Sponsor

Conditions

Breast Neoplasms 113 Colorectal Neoplasms 73 Stomach Neoplasms 47 Pancreatic Neoplasms 45 Rectal Neoplasms 40 Neoplasms 29 Neoplasm Metastasis 29 Colonic Neoplasms 18 Esophageal Neoplasms 16 Triple Negative Breast Neoplasms 13 Adenocarcinoma 11 Parkinson Disease 4, Autosomal Dominant Lewy Body 9 Gallbladder Neoplasms 9 Bile Duct Neoplasms 8 Brain Neoplasms 7 Adenocarcinoma Of Esophagus 7 Liver Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Cholangiocarcinoma 5 Breast Neoplasms, Male 5 Somatostatinoma 4 Head and Neck Neoplasms 4 Carcinoma, Hepatocellular 4 Biliary Tract Neoplasms 4 Gastrointestinal Neoplasms 3 Gastrinoma 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Squamous Cell 3 Carcinoma, Renal Cell 3 Solid Tumor 2

Interventions

fludarabine phosphate 31 Cyclophosphamide 27 Mycophenolic Acid 22 Whole-Body Irradiation 21 Tacrolimus 21 Peripheral Blood Stem Cell Transplantation 19 Busulfan 19 ruxolitinib 17 Antilymphocyte Serum 16 fludarabine 14 Melphalan 12 Methotrexate 11 Cyclosporine 10 thymoglobulin 9 Cord Blood Stem Cell Transplantation 7 Sirolimus 6 Radiotherapy 6 Etoposide 6 Azacitidine 6 Granulocyte Colony-Stimulating Factor 5 Stem Cell Transplantation 4 Cyclosporins 4 pomalidomide 3 parsaclisib 3 Surveys and Questionnaires 3 Rituximab 3 Prednisone 3 Filgrastim 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 sargramostim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡